BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2006
View Archived Issues
Leuprolide beneficial in phase II Alzheimer's disease study
Read More
Phase II studies show anemia correction with CERA in chronic kidney disease
Read More
Phase IIa study of LAB CGRP begins enrollment
Read More
Chimerix signs CRADA with U.S. Army for smallpox therapeutic CMX-001
Read More
Enrollment begins in phase III Bronchitol study
Read More
Vectura to work with Boehringer Ingelheim on dry powder inhaler
Read More
CEL-1000 shows adjuvant activity with malaria vaccines
Read More
ACP-103 increases slow wave sleep in clinical study
Read More
Pilot study of MM-093 in psoriasis completes enrollment
Read More
Bio-E-Gel NDA accepted for review
Read More
End of phase II testing of diquafosol in Asia triggers milestone payment
Read More
Enrollment completed in pivotal study of IL-Trap for CAPS
Read More
Stressgen to focus on reformulated HspE7
Read More
NIAID funds development of VivaGel for genital herpes
Read More
New evidence that selective M3 muscarinic antagonists can inhibit tumor growth
Read More
Feeding-suppressive properties of new orally active NPY Y5 antagonist
Read More
Antiangiogenic efficacy of a new multiple RTK inhibitor from Roche
Read More
Endocyte investigates folate-targeted cytotoxic anticancer drug in phase I study
Read More
Meditor begins phase II trial for MTR-104 in intradialytic hypotension
Read More
Yaz now available
Read More
Alteon and HaptoGuard to merge
Read More
Takeda and Lilly conclude U.S. Actos marketing collaboration
Read More
Pozen completes SPA for PN-200
Read More
European Commission approves Prograf for use in heart transplantation
Read More
Recent patents cover therapeutic agents for neurological disorders
Read More
Novel treatment options for endocrine-related disorders disclosed in recent patents
Read More
Therapeutic agents for cardiovascular disorders disclosed in recent patents
Read More
Dual muscarinic M3 receptor antagonists and PDE4 inhibitors potentially effective for COPD
Read More
Novel agent for the management of acute renal failure in sepsis
Read More